TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 60 filers reported holding TYRA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,517,647 | -14.8% | 110,214 | +5.3% | 0.00% | -100.0% |
| Q2 2023 | $1,782,309 | +8.3% | 104,657 | +2.2% | 0.00% | – |
| Q1 2023 | $1,645,086 | +119.7% | 102,370 | +3.9% | 0.00% | – |
| Q4 2022 | $748,623 | -11.5% | 98,503 | +2.4% | 0.00% | – |
| Q3 2022 | $846,000 | +45.4% | 96,175 | +18.3% | 0.00% | – |
| Q2 2022 | $582,000 | -32.4% | 81,301 | +1.1% | 0.00% | – |
| Q1 2022 | $861,000 | -22.9% | 80,456 | +1.4% | 0.00% | – |
| Q4 2021 | $1,117,000 | – | 79,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
| Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
| Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
| TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
| Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
| RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
| BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
| Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
| Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |